Balfour, H.H., Jr.; Meirhaeghe, M.R.; Stancari, A.L.; Geris, J.M.; Condon, L.M.; Cederberg, L.E.
Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine. Vaccines 2022, 10, 1399.
https://doi.org/10.3390/vaccines10091399
AMA Style
Balfour HH Jr., Meirhaeghe MR, Stancari AL, Geris JM, Condon LM, Cederberg LE.
Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine. Vaccines. 2022; 10(9):1399.
https://doi.org/10.3390/vaccines10091399
Chicago/Turabian Style
Balfour, Henry H., Jr., Madeline R. Meirhaeghe, Arianna L. Stancari, Jennifer M. Geris, Lawrence M. Condon, and Laurel E. Cederberg.
2022. "Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine" Vaccines 10, no. 9: 1399.
https://doi.org/10.3390/vaccines10091399
APA Style
Balfour, H. H., Jr., Meirhaeghe, M. R., Stancari, A. L., Geris, J. M., Condon, L. M., & Cederberg, L. E.
(2022). Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine. Vaccines, 10(9), 1399.
https://doi.org/10.3390/vaccines10091399